Skip to Content

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • GOG 0277

    A Phase III Randomized Trail of Gemcitabine (NSC#613327 Plus Docetaxel (NSC# 628503) followed By Doxorubicin (NSC#123127) Versus Observation for Uterus Limited, High-Grade Uterine Leiomyosarcoma

Showing trial 1 of 1

Also in this Section